Literature DB >> 22762043

Implantation of Iakymenko keratoprosthesis in patients with severe ocular injury.

Hong-Wei Pan1, Stanislav Iakymenko, Jin-Tang Xu, Guang-Hui Hou, Bing-Ji Sun, A-Ning Zheng.   

Abstract

AIM: To present the results of implantation of Iakymenko keratoprosthesis in five patients with vascularized corneal leukoma caused by severe ocular injury.
METHODS: Iakymenko keratoprosthesis was implanted into 5 eyes of 5 patients: 4 patients were suffered from chemical burns and 1 patient from explosive injury. The preoperative visual acuity ranged from light perception to hand motion. The implantation surgery was composed of two-stage procedures. The follow-up period was from 9 months to 11 years. The outcome measures were visual acuity, retention, and complications of the keratoprosthesis.
RESULTS: Vision improvements were achieved in most patients. All keratoprosthesis were retained within the follow-up period. Corneal melting occurred in one patient and fibrous closure in another patient, both of which were successfully treated. Retinal detachment occurred in one patient after surgery.
CONCLUSION: Iakymenko keratoprosthesis seems to be a promising alternative for the patients with severe corneal injury, but further investigation is needed to evaluate the role of Iakymenko keratoprosthesis.

Entities:  

Keywords:  Iakymenko keratoprosthesis; complications; visual rehabilitation

Year:  2012        PMID: 22762043      PMCID: PMC3359031          DOI: 10.3980/j.issn.2222-3959.2012.02.10

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  18 in total

1.  Keratoprosthesis in China.

Authors:  Jifeng Yu; Yifei Huang
Journal:  Am J Ophthalmol       Date:  2010-08       Impact factor: 5.258

Review 2.  Keratoprostheses in clinical practice - a review.

Authors:  Ahmed Gomaa; Oliver Comyn; Christopher Liu
Journal:  Clin Exp Ophthalmol       Date:  2010-03       Impact factor: 4.207

3.  Keratoprosthesis: the Dohlman-Doane device.

Authors:  James V Aquavella; Ying Qian; Gregory J McCormick; Jayachandra Reddy Palakuru
Journal:  Am J Ophthalmol       Date:  2005-12       Impact factor: 5.258

4.  Moscow eye microsurgery complex in Russia keratoprosthesis in Beijing.

Authors:  Yifei Huang; Jifeng Yu; Li Liu; Gaiping Du; Jing Song; Huiling Guo
Journal:  Ophthalmology       Date:  2010-09-01       Impact factor: 12.079

5.  The Chirila Keratoprosthesis: phase I human clinical trial.

Authors:  Geoffrey J Crawford; Celia R Hicks; Xia Lou; Sarojini Vijayasekaran; Donald Tan; Bridget Mulholland; Traian V Chirila; Ian J Constable
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

6.  Legeais BioKpro III keratoprosthesis implantation: long term results in seven patients.

Authors:  E J Hollick; S L Watson; J K G Dart; P J Luthert; B D S Allan
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

7.  AlphaCor: Clinical outcomes.

Authors:  Celia R Hicks; Geoffrey J Crawford; John K G Dart; Günther Grabner; Edward J Holland; R Doyle Stulting; Donald T Tan; Max Bulsara
Journal:  Cornea       Date:  2006-10       Impact factor: 2.651

8.  Cost-effectiveness of the Boston keratoprosthesis.

Authors:  Jared D Ament; Tomasz P Stryjewski; Joseph B Ciolino; Amit Todani; James Chodosh; Claes H Dohlman
Journal:  Am J Ophthalmol       Date:  2009-11-24       Impact factor: 5.258

9.  AlphaCor keratoprosthesis: postoperative development of six patients.

Authors:  S A Holak; H M Holak; H Bleckmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-22       Impact factor: 3.117

10.  Keratoprosthesis surgery for end-stage corneal blindness in asian eyes.

Authors:  Donald T H Tan; Andrew B G Tay; Julian T S Theng; Kok-Weng Lye; Anand Parthasarathy; Yong-Ming Por; Ling-Ling Chan; Christopher Liu
Journal:  Ophthalmology       Date:  2008-03       Impact factor: 12.079

View more
  1 in total

1.  Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases.

Authors:  Stanislav Iakymenko
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.